


Searching News Database: bacterial vaginosis
HSMN NewsFeed - 18 Jan 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
HSMN NewsFeed - 11 Apr 2022
Evofem Announces Karina Fedasz as Company's New Head of Business Development
Evofem Announces Karina Fedasz as Company's New Head of Business Development
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
HSMN NewsFeed - 23 Oct 2012
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
HSMN NewsFeed - 20 Jan 2009
Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer
Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer
HSMN NewsFeed - 26 Sep 2007
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
HSMN NewsFeed - 31 Jul 2007
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
HSMN NewsFeed - 9 Nov 2006
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
HSMN NewsFeed - 8 May 2006
Mission Pharmacal Completes Phase III Study of Tindamax(R) for the Treatment of Bacterial Vaginosis
Mission Pharmacal Completes Phase III Study of Tindamax(R) for the Treatment of Bacterial Vaginosis
Additional items found! 20
Members Archive contains
20 additional stories matching:
bacterial vaginosis
(Password required)
bacterial vaginosis
(Password required)
